This technology is an encouraging step forward in drug delivery and ...
PHN is a painful nerve condition that lingers after a shingles ...
The FDA has approved the first biosimilar product, Zarxio (filgrastim-sndz). Do you consider this a breakthrough?
Yes, like generic drugs, this will help reduce costs.
No, a biological agent could never be considered identical.